Harrow Health to Announce Second Quarter 2022 Financial Results on August 9, 2022
July 27 2022 - 7:00AM
Business Wire
Harrow Health, Inc. (Nasdaq: HROW), an eye health pharmaceutical
company focused on the development, production, sale, and
distribution of innovative ophthalmic prescription medications that
are accessible and affordable, today announced that it will release
its financial results for the second quarter ended June 30, 2022,
on Tuesday, August 9, 2022, after the market close. The Company
will also post its second quarter Letter to Stockholders to the
“Investors” section of its website, harrowinc.com. Harrow Health
will host a conference call and live webcast at 4:45 p.m. Eastern
Time to discuss the results and provide a business update.
Conference Call Details:
Date:
Tuesday, August 9, 2022
Time:
4:45 p.m. Eastern time
Participant Dial-in:
1-833-953-2434 (U.S.)
1-412-317-5763 (International)
Replay Dial-in (Passcode
8466369):
(telephonic replay through August 16,
2022)
1-877-344-7529 (U.S.)
1-412-317-0088 (International)
Webcast: (online replay through
November 9, 2022)
harrowinc.com
About Harrow Health Harrow Health, Inc. (Nasdaq: HROW) is
an eye health pharmaceutical company focused on the development,
production, sale, and distribution of innovative ophthalmic
prescription medications that are accessible and affordable. For
more information about Harrow Health, please visit the Investors
section of the corporate website, harrowinc.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220727005305/en/
Jamie Webb, Director of Communications and Investor Relations
jwebb@harrowinc.com 615-733-4737
Harrow (NASDAQ:HROW)
Historical Stock Chart
From Mar 2024 to Apr 2024
Harrow (NASDAQ:HROW)
Historical Stock Chart
From Apr 2023 to Apr 2024